| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.61B | 49.37B | 49.16B | 44.10B | 39.66B | 38.85B |
| Gross Profit | 13.73B | 15.20B | 13.54B | 11.70B | 9.95B | 10.24B |
| EBITDA | 3.45B | 4.40B | 3.94B | 2.99B | 2.02B | 2.81B |
| Net Income | 1.61B | 2.54B | 2.01B | 1.31B | 1.02B | 1.65B |
Balance Sheet | ||||||
| Total Assets | 63.12B | 64.44B | 63.73B | 62.23B | 52.13B | 52.08B |
| Cash, Cash Equivalents and Short-Term Investments | 14.69B | 11.48B | 14.04B | 15.55B | 10.32B | 12.44B |
| Total Debt | 10.19B | 8.00B | 10.28B | 10.72B | 5.78B | 3.82B |
| Total Liabilities | 29.25B | 27.03B | 29.16B | 29.14B | 20.52B | 20.03B |
| Stockholders Equity | 33.83B | 37.40B | 34.55B | 33.03B | 31.64B | 32.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 588.00M | 76.00M | 2.01B | -3.82B | 527.00M |
| Operating Cash Flow | 0.00 | 2.59B | 2.99B | 4.33B | -1.64B | 2.22B |
| Investing Cash Flow | 0.00 | -1.43B | -2.81B | -2.33B | -1.23B | -2.17B |
| Financing Cash Flow | 0.00 | -3.78B | -1.75B | 3.19B | 710.00M | -282.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥319.97B | 18.05 | ― | 2.99% | 5.65% | 11.14% | |
74 Outperform | ¥85.15B | 6.79 | ― | 4.79% | 0.52% | 20.09% | |
70 Outperform | ¥3.03T | 9.53 | 7.55% | 2.22% | 5.51% | 12.24% | |
68 Neutral | ¥31.46B | 11.85 | ― | 4.26% | 0.43% | 25.95% | |
68 Neutral | ¥11.09B | 5.27 | ― | 3.58% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥43.05B | 5.84 | ― | 1.56% | 11.98% | ― |